Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2025-12-17 @ 1:00 AM
Study NCT ID:
NCT04484675
Status:
None
Last Update Posted:
2025-04-30 00:00:00
First Post:
2020-07-13 00:00:00
Brief Title:
Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension
Sponsor:
Zagazig University
Organization:
Zagazig University
Study Overview
Official Title:
Comparative Study Between Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension Undergoing Cardiac Surgery
Status:
None
Status Verified Date:
2025-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Milrinone is widely used in cardiac surgery as an inotrope and pulmonary vasodilator agent But , intravenous milrinone has been associated with systemic hypotension and increased requirement for vasoactive drugs
The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery
The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery
Detailed Description:
Milrinone is widely used in cardiac surgery as an inotrope and pulmonary vasodilator agent But intravenous milrinone has been associated with systemic hypotension and increased requirement for vasoactive drugs
The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery
The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None